Glucose-mediated Repression of Menin Promotes Pancreatic Β-Cell Proliferation.

Hongli Zhang,Wenyi Li,Qidi Wang,Xiao Wang,Fengying Li,Cuiping Zhang,Ling Wu,Hongmei Long,Yun Liu,Xiaoying Li,Min Luo,Guo Li,Guang Ning
DOI: https://doi.org/10.1210/en.2011-1460
IF: 5.051
2011-01-01
Endocrinology
Abstract:Menin, encoded by the Men1 gene, is responsible for β-cell tumor formation in patients with multiple endocrine neoplasia type 1. Recently, menin has been proven to negatively regulate β-cell proliferation during pregnancy. However, it is unclear whether menin is involved in pancreatic β-cell proliferation in response to other physiological replication stimuli, such as glucose. In this study, we found that the menin level was significantly reduced in high glucose-treated INS1 cells and primary rat islets, both with increased proliferation. A similar observation was found in islets isolated from rats subjected to 72-h continuous glucose infusion. The glucose-induced proliferation was inhibited by menin overexpression. Further molecular studies showed that glucose-induced menin suppression was blocked by PI3K/Akt pathway inhibitors. A major PI3K/Akt substrate, Foxo1, was shown to enhance menin transcription levels by binding the promoter region of the Men1 gene. Therefore, we conclude that glucose inhibits menin expression via the PI3K/Akt/Foxo1 pathway and hence promotes pancreatic β-cell proliferation. Our study suggests that menin might serve as an important intracellular target of glucose to mediate the mitogenic effect that glucose exerts in pancreatic β-cells.
What problem does this paper attempt to address?